Captive Insurance Times today opens its Healthcare Captive Survey 2026/27, inviting practitioners across the group medical captive market to share how they are managing rising medical costs, specialty pharmacy pressures and the shifting domicile landscape. The survey gathers benchmark data on how healthcare captives are performing and where the market is heading, with the results forming the editorial backbone of the Healthcare Captive Annual, published on 24 September 2026. Structured around four core sections covering domicile growth, regulation, tax and the role of artificial intelligence, the survey is designed to track sentiment year on year. It asks respondents to weigh claimed benefits against proven returns, probing questions such as the rate at which healthcare captives are paying dividends or premium refunds, and the outlook for growth over the coming year. Several questions target the pressures reshaping medical stop-loss and group medical captive programmes. Respondents are asked how GLP-1 and specialty pharmacy costs are affecting their arrangements, whether stop-loss pricing is hardening at renewal, and which barriers are holding back wider adoption of the captive model for employee benefits. The domicile question invites participants to name where they expect the strongest healthcare captive growth, drawing on a comprehensive list spanning established and emerging jurisdictions, from Vermont, Hawaii and Bermuda to the Cayman Islands and beyond. The survey is open now and closes on 14 August 2026. Practitioners, brokers, advisers and captive managers active in the healthcare space are encouraged to take part. Take the Healthcare Captive Survey 2026/27 here.
